Singapore: Naviscan, the global leader in organ-specific molecular imaging, received Shonin approval from the Japanese M...
Tokyo: Japanese pharmaceutical giant, Daiichi Sankyo Company Limited has announced that its wholly-owned subsidiary in ...
Singapore: Chugai Pharmaceutical and US-based Athersys have entered into a partnership and license agreement to exclusiv...
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Japanese major Takeda Pharmaceutical C...
Roche has announced that the company has entered into an agreement to develop a companion diagnostic (CDx) test for dalc...
Carna Biosciences has signed a worldwide licensing agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutica...
Singapore: Millennium Research Group (MRG) estimates that transcatheter aortic valve replacement (TAVR) devices will be ...
Daiichi Sankyo Company Limited has initiated its Hokusai-VTE Cancer, a multinational study which will investigate the ef...
Tokyo: Australia's regenerative medicine company, Mesoblast Limited has announced that its allogeneic mesenchymal stem c...
Tokyo: Cambridge-based Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology...
Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major suppli...
Japanese pharma major Daiichi Sankyo Company Limited has announced the completion of the merger process of its subsidiar...
New York-based Progenics Pharmaceuticals' partner Fujifilm RI Pharma Co. Ltd. (Fuji) has dosed the first patient in its ...
Japan' Daiichi Sankyo's domestic subsidiary, Daiichi Sankyo Espha Co Ltd. has obtained approval for partial changes conc...
Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...
Singapore: South Korea-based global healthcare enterprise, CHA Health Systems has inked a pact with Japanese medical cor...
Singapore: Japan's Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement...
Singapore: Japanese drugmaker Takeda has inked a 10-year pact with Japan's Kyoto University to co-develop stem cell ther...
